ACS Medicinal Chemistry Letters
Technology Note
engineered human beta2-adrenergic G protein-coupled receptor. Science
2007, 318, 1258−1265.
(19) Rosenbaum, D. M.; Cherezov, V.; Hanson, M. A.; Rasmussen, S.
G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Yao, X. J.; Weis, W. I.;
Stevens, R. C.; Kobilka, B. K. GPCR engineering yields high-resolution
structural insights into beta2-adrenergic receptor function. Science 2007,
318, 1266−1273.
(20) Kolb, P.; Rosenbaum, D. M.; Irwin, J. J.; Fung, J. J.; Kobilka, B. K.;
Shoichet, B. K. Structure-based discovery of beta2-adrenergic receptor
ligands. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 6843−6848.
(21) Rasmussen, S. G.; DeVree, B. T.; Zou, Y.; Kruse, A. C.; Chung, K.
Y.; Kobilka, T. S.; Thian, F. S.; Chae, P. S.; Pardon, E.; Calinski, D.;
Mathiesen, J. M.; Shah, S. T.; Lyons, J. A.; Caffrey, M.; Gellman, S. H.;
Steyaert, J.; Skiniotis, G.; Weis, W. I.; Sunahara, R. K.; Kobilka, B. K.
Crystal structure of the β2 adrenergic receptor-Gs protein complex.
Nature 2011, 477, 549−555.
(22) Kobilka, B. K. Amino and carboxyl terminal modifications to
facilitate the production and purification of a G protein-coupled
receptor. Anal. Biochem. 1996, 231, 269−71.
(23) Baker, J. G. The selectivity of beta-adrenoceptor antagonists at the
human beta1, beta2 and beta3 adrenoceptors. Br. J. Pharmacol. 2005,
144, 317−322.
(24) January, B.; Seibold, A.; Whaley, B.; Hipkin, R. W.; Lin, D.;
Schonbrunn, A.; Barber, R.; Clark, R. B. Beta2-adrenergic receptor
desensitization, internalization, and phosphorylation in response to full
and partial agonists. J. Biol. Chem. 1997, 272, 23871−23879.
(25) Rasmussen, S. G.; Choi, H. J.; Fung, J. J.; Pardon, E.; Casarosa, P.;
Chae, P. S.; Devree, B. T.; Rosenbaum, D. M.; Thian, F. S.; Kobilka, T.
S.; Schnapp, A.; Konetzki, I.; Sunahara, R. K.; Gellman, S. H.; Pautsch,
A.; Steyaert, J.; Weis, W. I.; Kobilka, B. K. Structure of a nanobody-
stabilized active state of the β2 adrenoceptor. Nature 2011, 469, 175−
180.
REFERENCES
■
(1) Murray, C.; Rees, D. C. The rise of fragment-based drug discovery.
Nat. Chem. 2009, 1, 187−192.
(2) Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful
metric for lead selection. Drug Discovery Today 2004, 9, 430−431.
(3) Verheij, M. H.; de Graaf, C.; de Kloe, G. E.; Nijmeijer, S.; Vischer,
H. F.; Smits, R. A.; Zuiderveld, O. P.; Hulscher, S.; Silvestri, L.;
Thompson, A. J.; van Muijlwijk-Koezen, J. E.; Lummis, S. C.; Leurs, R.;
de Esch, I. J. Fragment library screening reveals remarkable similarities
between the G protein-coupled receptor histamine H4 and the ion
channel serotonin 5-HT3A. Bioorg. Med. Chem. Lett. 2011, 21, 5460−
5464.
(4) Stoddart, L. A.; Vernall, A. J.; Denman, J. L.; Briddon, S. J.; Kellam,
B.; Hill, S. J. Fragment screening at adenosine-A3 receptors in living cells
using a fluorescence-based binding assay. Chem. Biol. 2012, 19, 1105−
15.
(5) Navratilova, I.; Hopkins, A. L. Fragment screening by surface
plasmon resonance. ACS Med. Chem. Lett. 2010, 1, 44−48.
(6) Navratilova, I.; Besnard, J.; Hopkins, A. L. Screening for GPCR
ligands using surface plasmon resonance. ACS Med. Chem. Lett. 2011, 2,
549−554.
(7) Navratilova, I.; Pancera, M.; Wyatt, R. T.; Myszka, D. G. A
biosensor-based approach toward purification and crystallization of G
protein-coupled receptors. Anal. Biochem. 2006, 353, 278−283.
(8) Congreve, M.; Rich, R. L.; Myszka, D. G.; Figaroa, F.; Siegal, G.;
Marshall, F. H. Fragment screening of stabilized G-protein-coupled
receptors using biophysical methods. Methods Enzymol. 2011, 493,
115−136.
(9) Chen, D.; Errey, J. C.; Heitman, L. H.; Marshall, F. H.; Ijzerman, A.
P.; Siegal, G. Fragment screening of GPCRs using biophysical methods:
Identification of ligands of the adenosine A(2A) receptor with novel
biological activity. ACS Chem. Biol. 2012, 7, 2064−2073.
́
(10) Christopher, J. A.; Brown, J.; Dore, A. S.; Errey, J. C.; Koglin, M.;
Marshall, F. H.; Myszka, D. G.; Rich, R. L.; Tate, C. G.; Tehan, B.;
Warne, T.; Congreve, M. Biophysical fragment screening of the β1-
adrenergic receptor: identification of high affinity arylpiperazine leads
using structure-based drug design. J. Med. Chem. 2013, 56, 3446−3455.
(11) Robertson, N.; Jazayeri, A.; Errey, J.; Baig, A.; Hurrell, E.; Zhukov,
A.; Langmead, C. J.; Weir, M.; Marshall, F. H. The properties of
thermostabilised G protein-coupled receptors (StaRs) and their use in
drug discovery. Neuropharmacology 2011, 60, 36−44.
(12) Magnani, F.; Shibata, Y.; Serrano-Vega, M. J.; Tate, C. G. Co-
evolving stability and conformational homogeneity of the human
adenosine A2a receptor. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 10744−
10749.
(13) Serrano-Vega, M. J.; Magnani, F.; Shibata, Y.; Tate, C. G.
Conformational thermostabilization of the beta1-adrenergic receptor in
a detergent-resistant form. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 877−
882.
(14) Navratilova, I.; Sodroski, J.; Myszka, D. G. Solubilization,
stabilization, and purification of chemokine receptors using biosensor
technology. Anal. Biochem. 2005, 339, 271−281.
(15) Navratilova, I.; Dioszegi, M.; Myszka, D. G. Analyzing ligand and
small molecule binding activity of solubilized GPCRs using biosensor
technology. Anal. Biochem. 2006, 355, 132−139.
(16) Dixon, R. A.; Kobilka, B. K.; Strader, D. J.; Benovic, J. L.;
Dohlman, H. G.; Frielle, T.; Bolanowski, M. A.; Bennett, C. D.; Rands,
E.; Diehl, R. E.; Mumford, R. A.; Slater, E. E.; Sigal, I. S.; Caron, M. G.;
Lefkowitz, R. J.; Strader, C. D. Cloning of the gene and cDNA for
mammalian beta-adrenergic receptor and homology with rhodopsin.
Nature 1986, 321, 75−79.
(17) Rasmussen, S. G.; Choi, H. J.; Rosenbaum, D. M.; Kobilka, T. S.;
Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R.; Sanishvili,
R.; Fischetti, R. F.; Schertler, G. F.; Weis, W. I.; Kobilka, B. K. Crystal
structure of the human beta2 adrenergic G-protein-coupled receptor.
Nature 2007, 450, 383−387.
(18) Cherezov, V.; Rosenbaum, D. M.; Hanson, M. A.; Rasmussen, S.
G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Kuhn, P.; Weis, W. I.;
Kobilka, B. K.; Stevens, R. C. High-resolution crystal structure of an
F
dx.doi.org/10.1021/ml400312j | ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX